CompletedNot Applicable

Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin

Taiwan164 participantsStarted 2007-09

Plain-language summary

To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.

Who can participate

Age range1 Day – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * infantile esotropia and acquired esotropia Exclusion Criteria: * exotropia, high AC/A ratio accommodative esotropia, patients with neurological deficit including cerebral palsy, Down syndrome and mental retardation, and ocular anomalies including retinopathy of prematurity. Patients lost to follow-up at 6 months or less after the last injection were also excluded.

What they're measuring

Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications.

Timeframe: Before treatment, weekly after the treatment, and monthly after motor alignment

Trial details

NCT IDNCT00746304

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2007-10

View on ClinicalTrials.gov More Esotropia trials